Graham Casey

University of Virginia
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (12)

Supplementary Figure S5 shows the age-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.

Year:

2025

Supplementary Figure S4 shows the family-history-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.

Year:

2025

Background: Tobacco smoking is an established risk factor for colorectal cancer. However, genetically defined population subgroups may have increased susceptibility to smoking-related effects on colorectal cancer. Methods: A genome-wide interaction scan was performed including 33,756 colorectal cancer cases and 44,346 controls from three genetic consortia. Results: Evidence of an interaction was observed between smoking status (ever vs. never smokers) and a locus on 3p12.1 (rs9880919, P = 4.58 × 10 −8 ), with higher associated risk in subjects carrying the GG genotype [OR, 1.25; 95% confidence interval (CI), 1.20–1.30] compared with the other genotypes (OR P = 1.72 × 10 −8 ) and 8q24.23 (rs7005722, P = 2.88 × 10 −8 ). Subjects carrying the rs4151657 TT genotype showed higher risk (OR, 1.12; 95% CI, 1.09–1.16) compared with the other genotypes (OR CADM2 (3p12.1) and ATF6B (6p21.33). Conclusions: Our study identified novel genetic loci that may modulate the risk for colorectal cancer of smoking status and intensity, linked to tumor suppression and immune response. Impact: These findings can guide potential prevention treatments.

Year:

2025

Supplementary Figure S2 shows the sex-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.

Year:

2025

Background: Polygenic risk scores (PRS) which summarize individuals’ genetic risk profile may enhance targeted colorectal cancer screening. A critical step towards clinical implementation is rigorous external validations in large community-based cohorts. This study externally validated a PRS-enhanced colorectal cancer risk model comprising 140 known colorectal cancer loci to provide a comprehensive assessment on prediction performance. Methods: The model was developed using 20,338 individuals and externally validated in a community-based cohort ( n = 85,221). We validated predicted 5-year absolute colorectal cancer risk, including calibration using expected-to-observed case ratios (E/O) and calibration plots, and discriminatory accuracy using time-dependent AUC. The PRS-related improvement in AUC, sensitivity and specificity were assessed in individuals of age 45 to 74 years (screening-eligible age group) and 40 to 49 years with no endoscopy history (younger-age group). Results: In European-ancestral individuals, the predicted 5-year risk calibrated well [E/O = 1.01; 95% confidence interval (CI), 0.91–1.13] and had high discriminatory accuracy (AUC = 0.73; 95% CI, 0.71–0.76). Adding the PRS to a model with age, sex, family and endoscopy history improved the 5-year AUC by 0.06 ( P P = 0.05) in the screening-eligible age and younger-age groups, respectively. Using a risk-threshold of 5-year SEER colorectal cancer incidence rate at age 50 years, adding the PRS had a similar sensitivity but improved the specificity by 11% ( P P = 0.04) with similar specificity. Conclusions: The proposed PRS-enhanced model provides a well-calibrated 5-year colorectal cancer risk prediction and improves discriminatory accuracy in the external cohort. Impact: The proposed model has potential utility in risk-stratified colorectal cancer prevention.

Year:

2025

Supplementary Figure S3 shows the endoscopy-history-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.

Year:

2025

Supplementary methods show the details of study population, risk model development, calculation of the polygenic risk score, statistical analysis and funding of individual studies in GECCO and CORECT.

Year:

2025

Colorectal cancer risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Gene-environment interactions (G × E) can provide biological insights into the effects of obesity on colorectal cancer risk. Here, we assessed potential genome-wide G × E interactions between body mass index (BMI) and common SNPs for colorectal cancer risk using data from 36,415 colorectal cancer cases and 48,451 controls from three international colorectal cancer consortia (CCFR, CORECT, and GECCO). The G × E tests included the conventional logistic regression using multiplicative terms (one degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G × E interactions under specific conditions. BMI was associated with higher colorectal cancer risk. The two-step approach revealed a statistically significant G×BMI interaction located within the Formin 1/Gremlin 1 ( FMN1/GREM1 ) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher colorectal cancer risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with colorectal cancer risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and colorectal cancer. Significance: This gene-environment interaction analysis revealed a genetic locus in FMN1/GREM1 that interacts with body mass index in colorectal cancer risk, suggesting potential implications for precision prevention strategies.

Year:

2025

Colorectal cancer (CRC) risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Gene-environment (G×E) interactions can provide biological insights into the effects of obesity on CRC risk. Here, we assessed potential genome-wide G×E interactions between body mass index (BMI) and common single nucleotide polymorphisms (SNPs) for CRC risk using data from 36,415 CRC cases and 48,451 controls from three international CRC consortia (CCFR, CORECT, and GECCO). The G×E tests included the conventional logistic regression using multiplicative terms (one-degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G×E interactions under specific conditions. BMI was associated with higher CRC risk. The two-step approach revealed a statistically significant G×BMI interaction located within the Formin 1/Gremlin 1 (FMN1/GREM1) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher CRC risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with CRC risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and CRC.

Year:

2024

Alternative polyadenylation (APA) modulates mRNA processing in the 3′-untranslated regions (3′ UTR), affecting mRNA stability and translation efficiency. Research into genetically regulated APA has the potential to provide insights into cancer risk. In this study, we conducted large APA-wide association studies to investigate associations between APA levels and cancer risk. Genetic models were built to predict APA levels in multiple tissues using genotype and RNA sequencing data from 1,337 samples from the Genotype-Tissue Expression project. Associations of genetically predicted APA levels with cancer risk were assessed by applying the prediction models to data from large genome-wide association studies of six common cancers among European ancestry populations: breast, ovarian, prostate, colorectal, lung, and pancreatic cancers. A total of 58 risk genes (corresponding to 76 APA sites) were associated with at least one type of cancer, including 25 genes previously not linked to cancer susceptibility. Of the identified risk APAs, 97.4% and 26.3% were supported by 3′-UTR APA quantitative trait loci and colocalization analyses, respectively. Luciferase reporter assays for four selected putative regulatory 3′-UTR variants demonstrated that the risk alleles of 3′-UTR variants, rs324015 ( STAT6 ), rs2280503 ( DIP2B ), rs1128450 ( FBXO38 ), and rs145220637 ( LDHA ), significantly increased the posttranscriptional activities of their target genes compared with reference alleles. Furthermore, knockdown of the target genes confirmed their ability to promote proliferation and migration. Overall, this study provides insights into the role of APA in the genetic susceptibility to common cancers. Significance: Systematic evaluation of associations of alternative polyadenylation with cancer risk reveals 58 putative susceptibility genes, highlighting the contribution of genetically regulated alternative polyadenylation of 3′UTRs to genetic susceptibility to cancer.

Year:

2024

Year:

2024

Year:

2022

Collaborators (69)

Li Hsu

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Polly Newcomb

University of Washington

UNITED STATES
View details

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Tabitha Harrison

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Konstantinos K. Tsilidis

-

UNITED KINGDOM
View details

Victor Moreno

Professor

University of Barcelona

SPAIN
View details

Marina Evangelou

Senior Lecturer in Statistics

Imperial College London

UNITED KINGDOM
View details

Fränzel J.B. van Duijnhoven

Wageningen University & Research

NETHERLANDS
View details

Xiao‐Ou Shu

Vanderbilt University Medical Center

UNITED STATES
View details

Susanna Larsson

Professor at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Juan Pablo Lewinger

Associate Professor

University of Southern California

UNITED STATES
View details

John Baron

Professor

University of North Carolina

UNITED STATES
View details

David Drew

Assistant Professor of Medicine

Massachusetts General Hospital

UNITED STATES
View details

Qingrun Zhang

Assistant Professor

University of Calgary

CANADA
View details

Ulrike Peters

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Jihyoun Jeon

University of Michigan

UNITED STATES
View details

Matthew Devall

Assistant Professor

University of Virginia

UNITED STATES
View details

Sophia Harlid

Umea University

SWEDEN
View details

Eric Kawaguchi

Assistant Professor

University of Southern California

UNITED STATES
View details

Julie R Palmer

Boston University School of Medicine

UNITED STATES
View details

Wei Zheng

-

UNITED STATES
View details

Weiqiang Lin

Professor

Zhejiang University

CHINA
View details

Elizabeth Platz

Professor

Johns Hopkins University

UNITED STATES
View details

Yingye Zheng

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Mariana C. Stern

Professor

University of Southern California

UNITED STATES
View details

Qiuyin Cai

Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Tim Bishop

University of Leeds

UNITED KINGDOM
View details

Ran Tao

Associate Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Elizabeth Hauser

Duke University

UNITED STATES
View details

GUOCHONG JIA

Vanderbilt University

UNITED STATES
View details

Richard Hayes

Professor of Population Health and Environmental Medicine

NYU School of Medicine

UNITED STATES
View details

Mingyang Song

Associate Professor

Harvard University

UNITED STATES
View details

Stéphane Bézieau

Université de Nantes

FRANCE
View details

Virginia Díez-Obrero

Vrije Universiteit Amsterdam

NETHERLANDS
View details

Hongmei Nan

Professor

University of Indianapolis

UNITED STATES
View details

Zhishan Chen

staff Scientist

Vanderbilt University

UNITED STATES
View details

Emmanouil Bouras

Research associate

Imperial College London

UNITED KINGDOM
View details

Alicja Wolk

Professor of Nutritional Epidemiology

Karolinska Institutet

SWEDEN
View details

Anna H. Wu

Professor

University of Southern California

UNITED STATES
View details

John Potter

Professor

University of Washington

UNITED STATES
View details

Xingyi Guo

Associate Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Bethany Van Guelpen

Umea University

SWEDEN
View details

Li Li

University of Virginia

UNITED STATES
View details

Iris Lansdorp-Vogelaar

Associate Professor

Erasmus University Medical Center

NETHERLANDS
View details

Jirong Long

Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Andrea Burnett-Hartman

Epidemiologist Program Director

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Andrea Gsur

Medical University of Vienna

AUSTRIA
View details

Loic Le Marchand

Professor

University of Hawaii

UNITED STATES
View details

Edward A. Ruiz-Narváez

Associate Professor

University of Michigan School of Public Health

UNITED STATES
View details

Elom K Aglago

Imperial College London

UNITED KINGDOM
View details

David Conti

Professor

Colorado School of Public Health

UNITED STATES
View details

W. James Gauderman

professor

University of Southern California

UNITED STATES
View details

Paul Pharoah

Professor of Cancer Epidemiology

Cedars-Sinai Medical Center

UNITED STATES
View details

Yaohua Yang

Assistant Professor

University of Virginia

UNITED STATES
View details

Catherine Tangen

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Kala Visvanathan

Professor

Johns Hopkins University

UNITED STATES
View details

Daniel D. Buchanan

Senior Research Fellow

University of Melbourne

AUSTRALIA
View details

Annika Lindblom

Karolinska Institutet

SWEDEN
View details

Stephen Gruber

Professor

City Of Hope National Medical Center

UNITED STATES
View details

Jochen Hampe

Scientific Speaker

Technische Universität Dresden

GERMANY
View details

Anshul Kundaje

Associate Professor

Stanford University

UNITED STATES
View details

Mark Jenkins

University of Melbourne

AUSTRALIA
View details

Peter T. Campbell

Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Graham Giles

Head of Research

-

AUSTRALIA
View details

Michael Hoffmeister

Professor of Epidemiology, Group leader, Deputy divison head

German Cancer Research Center (DKFZ)

GERMANY
View details

Volker Arndt

Group leader

Deutsches Krebsforschungszentrum

GERMANY
View details

Elizabeth Barry

Associate Professor

Dartmouth College Geisel School of Medicine

UNITED STATES
View details

Pavel Vodička

senior researcher

Charles University

CZECH REPUBLIC
View details

Jennifer Ose

Professorin (W2)

Hochschule Hannover

GERMANY
View details